

Effectiveness of gabapentin in treatment of pain in patients with alcoholic polyneuropathy
https://doi.org/10.33667/2078-5631-2023-33-20-24
Abstract
Alcoholic polyneuropathy is a pressing problem in modern society. This neurological disease is characterized by impaired functions of many peripheral nerves due to the toxic effects of alcohol and its metabolites on nerve fibers. A study was conducted to assess the effectiveness of the use of Gabapentin-SZ (North Star Co., Russia) in alcohol polyneuropathy, involving 47 adult patients (31 men and 16 women). The study found significant efficacy of Gabapentin-SZ in treating pain in patients with alcohol polyneuropathy. Significant improvement was noted after 14 days of therapy.
About the Authors
V. V. GusevRussian Federation
Gusev Vadim V., PhD Med, assistant at Dept of Nervous Diseases, Neurosurgery and Medical Genetics1, senior researcher at Neurotechnology Laboratory
Ekaterinburg
O. V. Zaitseva
Russian Federation
Zaitseva Olga V., resident at Department of Nervous Diseases, Neurosurgery and Medical Genetics
Ekaterinburg
O. A. Lvova
Russian Federation
Lvova Olga A., DM Sci (habil.), associate professor, senior researcher at Laboratory of Intrauterine Programming of Central Research Laboratory, senior researcher at Neurotechnology Laboratory
Ekaterinburg
References
1. Levin O. S. Polyneuropathies: Clinical Guide. 3rd ed., rev. and additional M.: Medical Information Agency; 2016. 480 p.
2. Polyakova V. I. Features of detection, course, treatment and prognosis of toxic axonal sensorimotor polyneuropathy. Universe of the Brain. 2020; No. 3: 22–24.
3. Kurushina O. V., Barulin A. E., Chernovolenko E. P. Alcoholic polyneuropathy: Ways of diagnosis and therapy. Medical Council. 2019, No. 1. https://doi.org/10.21518/2079–701x‑2019–1–58–63
4. Pizova N. V. Basic metabolic and toxic polyneuropathies in clinical practice. Medical Council. 2021 (19): 134–146. https://doi.org/10.21518/2079–701x‑2021–19–134–146
5. Starykh E. V., Sokolova L. P. Neurological manifestations of alcoholism. Nervous diseases. 2022; No. 4: 19–25. https://doi.org/10.24412/2226–0757–2022–12931
6. Leonovich A. L., Shalkevich L. V., Kudlach A. I. Modern features of the development of neurological complications of chronic alcoholism. International Journal of Neurology. 2016; No. 6 (84): 70–77. https://doi.org/10.22141/2224–0713.6.84.2016.83123
7. Zinovieva O. E., Vashchenko N. V., Mozgovaya O. E., Yanakaeva T. A., Emelyanova A. Yu. Damage to the nervous system due to alcoholism. Neurology, neuropsychiatry, psychosomatics. 2019; 11: 83–88. https://doi.org/10.14412/2074–2711–2019–2S‑83–88
8. Levin O. S. General approaches to the treatment of polyneuropathies. Modern therapy in psychiatry and neurology. 2018; No. 1: 4–12.
9. Belskaya G. N., Sakharova E. A. Alcoholic polyneuropathy. Clinical forms and pathogenetically based approaches to therapy. Medical Council. 2021; (10): 94–99. https://doi.org/10.21518/2079–701x‑2021–10–94–99
10. Levin O. S., Nikitina A. Yu., Chimagomedova A. Sh. Modern principles of diagnosis and treatment of polyneuropathies. Modern Therapy in Psychiatry and Neurology. 2021; No. 3–4: 46–55.
11. Julian T, Glascow N, Syeed R, Zis P. Alcohol-related peripheral neuropathy: A systematic review and meta-analysis. J Neurol. 2019 Dec; 266 (12): 2907–2919. DOI: 10.1007/ s00415–018–9123–1. Epub 2018 Nov 22. PMID: 30467601; PMCID: PMC 6851213.
12. Chopra K, Tiwari V. Alcoholic neuropathy: Possible mechanisms and future treatment possibilities. Br J Clin Pharmacol. 2012 Mar; 73 (3): 348–62. DOI: 10.1111/j.1365–2125.2011.04111.x. PMID: 21988193; PMCID: PMC 3370340.
13. Dudek I, Hajduga D, Sienko C, Maani A, Sitarz E, Sitarz M, et al. Alcohol-Induced Neuropathy in Chronic Alcoholism: Causes, Pathophysiology, Diagnosis, and Treatment Options. Current Pathobiology Reports. 2020 Oct 23. 8: 87–97.
Review
For citations:
Gusev V.V., Zaitseva O.V., Lvova O.A. Effectiveness of gabapentin in treatment of pain in patients with alcoholic polyneuropathy. Medical alphabet. 2023;(33):20-24. (In Russ.) https://doi.org/10.33667/2078-5631-2023-33-20-24